Press Review

Key Takeaways On 20 December 2025, the ADHD press review spotlights the FDA’s historic clearance of LumosityRx as the first prescription digital therapeutic for adults with ADHD. This marks a significant shift in tech-driven neurodivergent care. The roundup covers new…

Key Takeaways On 19 December 2025, the Press Review highlights a 157% surge in ADHD stimulant prescriptions across Ontario, prompting renewed debate on overdiagnosis and long-term treatment. Prescriptions for ADHD stimulants in Ontario have risen 157%, raising concerns about potential…

Key Takeaways On 18 December 2025, the Press Review highlights the FDA’s clearance of LumosityRx, the first prescription digital app for adult ADHD training. This marks a significant development in ADHD neurodivergence news. The review covers advances in VR therapy,…

Key Takeaways Top story: FDA clears prescription Lumosity as a digital tool for adult ADHD treatment. ADHD diagnoses are rising, especially among women and working adults seeking support. Screen time in children is linked to smaller brain volume and increased…

Key Takeaways Top story: Studies link children’s increased social media use to a significant rise in ADHD diagnoses. Half of all individuals arrested in London may have undiagnosed ADHD, according to recent findings. Adult ADHD diagnoses have surged since COVID-19,…

Key Takeaways A new study finds that up to half of London arrests may involve people with undiagnosed ADHD, highlighting key neurodivergence and public health concerns as of 14 December 2025. Half of London arrests may involve undiagnosed ADHD, raising…

Key Takeaways Top story: Social media overuse is linked to reduced concentration in children with ADHD, according to new evidence. Undiagnosed ADHD may contribute to up to half of recent London arrests, a study suggests. Allowing children with ADHD to…

Key Takeaways Ontario has experienced a 157% increase in ADHD prescriptions since 2015, raising questions about overdiagnosis and developments in ADHD management strategies. ADHD prescription growth in Ontario highlights ongoing debate over diagnostic criteria and accessibility of care. Increased screen…

Key Takeaways Half of recent arrests in London may involve people with undiagnosed ADHD, highlighting gaps in recognition and support. New digital interventions, such as a recently approved prescription ADHD app, are expanding treatment options. Research links social media algorithms…

Key Takeaways AI productivity apps are evolving to support neurodivergent entrepreneurs, making workflows more adaptable and accessible. Advances in tools and systems are improving outcomes for individuals with ADHD, as highlighted in recent ADHD news and research. Key stories are…